JPH0451157B2 - - Google Patents

Info

Publication number
JPH0451157B2
JPH0451157B2 JP57016467A JP1646782A JPH0451157B2 JP H0451157 B2 JPH0451157 B2 JP H0451157B2 JP 57016467 A JP57016467 A JP 57016467A JP 1646782 A JP1646782 A JP 1646782A JP H0451157 B2 JPH0451157 B2 JP H0451157B2
Authority
JP
Japan
Prior art keywords
anandimycin
strain
antibiotic
agar
spore
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57016467A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57152897A (en
Inventor
Maikeru Beritsutsu Debitsudo
Aren Butsushu Jeemuzu
An Oheron Furanshisu
Ii Netsutoreton Junia Donarudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JPS57152897A publication Critical patent/JPS57152897A/ja
Publication of JPH0451157B2 publication Critical patent/JPH0451157B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
    • C12P17/162—Heterorings having oxygen atoms as the only ring heteroatoms, e.g. Lasalocid
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
JP57016467A 1981-02-20 1982-02-05 Fermenting method Granted JPS57152897A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/236,381 US4360595A (en) 1981-02-20 1981-02-20 Fermentation process for producing anandimycin

Publications (2)

Publication Number Publication Date
JPS57152897A JPS57152897A (en) 1982-09-21
JPH0451157B2 true JPH0451157B2 (https=) 1992-08-18

Family

ID=22889255

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57016467A Granted JPS57152897A (en) 1981-02-20 1982-02-05 Fermenting method

Country Status (2)

Country Link
US (1) US4360595A (https=)
JP (1) JPS57152897A (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4461831A (en) * 1982-08-16 1984-07-24 Bristol-Myers Company Antitumor agents albacarcins V and M
WO1997012220A2 (en) * 1995-09-15 1997-04-03 Samir Chachoua Method for the identification and therapeutic use of disease-associated organisms, elements and forces
US7799904B2 (en) * 2003-06-13 2010-09-21 University Of Kentucky Research Foundation Gilvocarcin gene cluster, recombinant production and use thereof
CN103214547B (zh) * 2013-03-05 2016-01-06 中国科学院微生物研究所 一种化合物及其在制备抗菌药物中的应用
CN107892680B (zh) * 2017-10-27 2020-11-10 北京大学 一种抗结核化合物及其合成方法与应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
AGRICULTURAL AND BIOLOGICAL CHEMISTRY=1980 *
CHEMICAL & PHARMACETICAL BULLETIN=1980 *

Also Published As

Publication number Publication date
US4360595A (en) 1982-11-23
JPS57152897A (en) 1982-09-21

Similar Documents

Publication Publication Date Title
EP0627009B1 (en) Macrocyclic lactones and a productive strain thereof
SU1308200A3 (ru) Способ получени биологически активного комплекса @ 6049 и штамм @ @ @ . @ . 6049-продуцент биологически активного комплекса @ 6049
JP2802097B2 (ja) 新規な制癌抗生物質ｍｉ４３―３７ｆ１１及びその製造法
JP2003509508A (ja) ミコフェノール酸およびその誘導体の製造方法
JPS6365679B2 (https=)
JPH0451157B2 (https=)
DE68916659T2 (de) WS-9326 A, WS-9326B und deren Derivate.
US4981954A (en) Novel azoxy compounds and process for production thereof
CA2229785A1 (en) Quinolone compounds for the treatment of disorders caused by helicobacter pylori
CA1232852A (en) Cl-1957b antibiotic compound and its production
GB2086394A (en) B-galctosidase inhibitor designated gt-2558 and derivatives thereof and microorganism for use in their preparation
US4301248A (en) Fermentation process for making rachelmycin
WO2010122669A1 (ja) 新規化合物アミコラマイシン、その製造方法及びその用途
JPS6310797A (ja) 抗生物質ｆ―０７６９
CA1063953A (en) Figaroic acid antibiotic complex from streptosporangium
JP3124373B2 (ja) 免疫抑制物質
JPS6015318B2 (ja) 新抗生物質ｓｆ−１９４２物質，その製造法およびそれを含有する抗ガン剤
JP2780828B2 (ja) ポリエーテル抗生物質ｍｉ２１５―ｎｆ３物質及びその製造法、並びに鶏のコクシジウム症の防除剤
JPH046720B2 (https=)
JPH06211615A (ja) Ｂｕ−４８０３ｔ抗生物質
JPS5849235B2 (ja) 新抗生物質ｘｋ−９９およびその製造法
CA1337934C (en) Macrolide compounds, their preparation and their use
JP2706843B2 (ja) 新規アントラキノン誘導体、その製造方法及び該誘導体を含有する抗腫瘍剤
JP2001055386A (ja) 抗生物質ツベラクトマイシンｂ、ｄおよびｅとその製造法
JPH0717979A (ja) 生理活性物質ＡＤ−２４−１ｂ